OKYO Pharma (OKYO) Net Shares Issued and Repurchased (2022 - 2026)

OKYO Pharma (OKYO) has reported Net Shares Issued and Repurchased for 5 consecutive years, with -$3.1 billion the latest figure, recorded in Q1 2026.

• On a quarterly basis, Net Shares Issued and Repurchased fell 3254959.18% year-over-year to -$3.1 billion in Q1 2026; TTM through Mar 2026 was -$3.1 billion, a 3254959.18% decrease from a year earlier, with the FY2026 full-year figure at -$3.1 billion, down 3254959.18% from the prior year.
• Net Shares Issued and Repurchased was -$3.1 billion for Q1 2026 at OKYO Pharma, down from -$94284.0 in the prior quarter.
• Over five years, Net Shares Issued and Repurchased peaked at -$12412.0 in Q1 2023 and troughed at -$3.1 billion in Q3 2025.
• A 5-year average of -$997.5 million and a median of -$94284.0 in 2025 frame the typical range for Net Shares Issued and Repurchased.
• Across the five-year window, Net Shares Issued and Repurchased plunged 11432384.69% in 2024 and surged 99.99% in 2025, its largest moves.
• Over 5 years, Net Shares Issued and Repurchased stood at -$19149.0 in 2022, then surged by 35.18% to -$12412.0 in 2023, then sank by 11432384.69% to -$1.4 billion in 2024, then surged by 99.99% to -$94284.0 in 2025, then sank by 3254959.18% to -$3.1 billion in 2026.
• The last three Net Shares Issued and Repurchased figures came in at -$3.1 billion (Q1 2026), -$94284.0 (Q4 2025), and -$3.1 billion (Q3 2025), per Business Quant data.